Access-site complications remain the most common complication from cardiac catheterization procedures, with reported incidence of 2%-3% in the current era. With the growing number of patients on chronic anticoagulation and antiplatelet medications who require venous access for cardiac procedures, we proposed that vascular closure devices (selected for characteristics optimal for venous closure) could deliver a safe and effective way to achieve rapid hemostasis, while also allowing for earlier ambulation times and shorter stays.
|Original language||English (US)|
|Journal||Vascular Disease Management|
|State||Published - Aug 2017|
- vascular closure device
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine